Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Ceva (CEVA), Qorvo (QRVO) and Change Healthcare (CHNG).
Ceva (CEVA)
In a report released today, Andrew Uerkwitz from Oppenheimer maintained a Hold rating on Ceva. The company’s shares closed last Thursday at $43.52, close to its 52-week high of $46.50.
According to TipRanks.com, Uerkwitz is a 5-star analyst with an average return of 24.2% and a 62.3% success rate. Uerkwitz covers the Technology sector, focusing on stocks such as Sonim Technologies, Axon Enterprise, and Unity Software.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ceva with a $49.33 average price target.
See today’s analyst top recommended stocks >>
Qorvo (QRVO)
In a report released today, Timothy Arcuri from UBS maintained a Hold rating on Qorvo, with a price target of $133.00. The company’s shares closed last Thursday at $146.39.
According to TipRanks.com, Arcuri is a top 100 analyst with an average return of 29.3% and a 72.9% success rate. Arcuri covers the Technology sector, focusing on stocks such as Advanced Micro Devices, Skyworks Solutions, and Texas Instruments.
Qorvo has an analyst consensus of Strong Buy, with a price target consensus of $159.67, a 14.9% upside from current levels. In a report released today, Barclays also maintained a Hold rating on the stock with a $160.00 price target.
Change Healthcare (CHNG)
Cantor Fitzgerald analyst Steven Halper maintained a Buy rating on Change Healthcare today and set a price target of $18.00. The company’s shares closed last Thursday at $15.29, close to its 52-week high of $15.54.
According to TipRanks.com, Halper is a 5-star analyst with an average return of 10.8% and a 57.6% success rate. Halper covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, NextGen Healthcare, and HealthStream.
Change Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $18.38, a 18.4% upside from current levels. In a report released yesterday, Raymond James also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
